Merck gets Humana's amended US antitrust claims over Zetia dismissed
MLex Summary: Merck was granted a motion to dismiss Humana’s US antitrust claims accusing it of entering into an illegal pay-for-delay agreement, which kept a generic version of the cholesterol drug...To view the full article, register now.
Already a subscriber? Click here to view full article